Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Janney Montgomery Scott Downgrades Salisbury Bancorp to Neutral

Janney Montgomery Scott Downgrades Salisbury Bancorp to Neutral

Janney Montgomery Scott analyst Jake Civiello downgrades Salisbury Bancorp (NASDAQ:SAL) from Buy to Neutral.

byBenzinga Newsdesk

December 6, 2022

1 minute read

Janney Montgomery Scott analyst Jake Civiello downgrades Salisbury Bancorp (NASDAQ:SAL) from Buy to Neutral.

Truist Securities Downgrades AnaptysBio to Hold, Lowers Price Target to $28

By Benzinga Newsdesk

September 13, 6:14 AM

Truist Securities analyst John Lee downgrades AnaptysBio (NASDAQ:ANAB) from Buy to Hold and lowers the price target from $50 to $28.

ANAB

Movers
News

What’s Going On With Ideanomics Stock Today?

By Erica Kollmann

August 25, 10:10 AM

Ideanomics, Inc. (NASDAQ: IDEX) shares are trading lower Friday.

IDEX

Media
News

Goodyear Tire Settles Wage Dispute In Malaysia: Reuters

By Shivani Kumaresan

September 14, 6:55 AM

Goodyear Tire & Rubber Co (NASDAQ:GT) has settled its labor dispute in the Malaysian factory with migrant workers, Reuters reported.…

Anixa Biosciences Announces Issuance Of Additional U.S. Patent For Ovarian Cancer Vaccine Technology

By Benzinga Newsdesk

October 3, 8:34 AM

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the U.S. Patent and Trademark Office (USPTO) has

ANIX

Janney Montgomery Scott Downgrades Salisbury Bancorp to Neutral

Related Posts

Truist Securities Downgrades AnaptysBio to Hold, Lowers Price Target to $28

What’s Going On With Ideanomics Stock Today?

Goodyear Tire Settles Wage Dispute In Malaysia: Reuters

Anixa Biosciences Announces Issuance Of Additional U.S. Patent For Ovarian Cancer Vaccine Technology